ATE328573T1 - Behandlung und zusammensetzungen zur erzielung eines hautalterungsschutzes durch corneum protease aktivatoren - Google Patents

Behandlung und zusammensetzungen zur erzielung eines hautalterungsschutzes durch corneum protease aktivatoren

Info

Publication number
ATE328573T1
ATE328573T1 AT00948721T AT00948721T ATE328573T1 AT E328573 T1 ATE328573 T1 AT E328573T1 AT 00948721 T AT00948721 T AT 00948721T AT 00948721 T AT00948721 T AT 00948721T AT E328573 T1 ATE328573 T1 AT E328573T1
Authority
AT
Austria
Prior art keywords
compositions
treatment
skin aging
aging protection
corneum protease
Prior art date
Application number
AT00948721T
Other languages
English (en)
Inventor
John R Schiltz
Original Assignee
Mary Kay Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23405006&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE328573(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mary Kay Inc filed Critical Mary Kay Inc
Application granted granted Critical
Publication of ATE328573T1 publication Critical patent/ATE328573T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00948721T 1999-07-20 2000-07-17 Behandlung und zusammensetzungen zur erzielung eines hautalterungsschutzes durch corneum protease aktivatoren ATE328573T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/357,288 US6495126B1 (en) 1999-07-20 1999-07-20 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation

Publications (1)

Publication Number Publication Date
ATE328573T1 true ATE328573T1 (de) 2006-06-15

Family

ID=23405006

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00948721T ATE328573T1 (de) 1999-07-20 2000-07-17 Behandlung und zusammensetzungen zur erzielung eines hautalterungsschutzes durch corneum protease aktivatoren

Country Status (24)

Country Link
US (11) US6495126B1 (de)
EP (1) EP1200063B1 (de)
KR (1) KR100768413B1 (de)
CN (1) CN1213730C (de)
AR (1) AR024813A1 (de)
AT (1) ATE328573T1 (de)
AU (1) AU772445B2 (de)
BR (1) BR0012567B1 (de)
CA (1) CA2379682C (de)
CZ (1) CZ300239B6 (de)
DE (1) DE60028573T2 (de)
EA (2) EA005099B1 (de)
ES (1) ES2265351T3 (de)
HK (1) HK1043942B (de)
MX (1) MXPA02000754A (de)
MY (1) MY128963A (de)
NO (1) NO20020299L (de)
NZ (1) NZ516940A (de)
PE (1) PE20010279A1 (de)
PL (1) PL352986A1 (de)
TW (1) TWI261522B (de)
UA (1) UA72533C2 (de)
UY (1) UY26255A1 (de)
WO (1) WO2001005369A1 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874463A (en) * 1994-10-24 1999-02-23 Ancira; Margaret Hydroxy-kojic acid skin peel
US6495126B1 (en) * 1999-07-20 2002-12-17 Mary Kay Inc. Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
EP1166765A3 (de) * 2000-06-20 2002-05-02 Laboratoires Serobiologiques Verfahren zum Schutz der menschlichen Haut
ITPN20010004A1 (it) * 2001-01-24 2002-07-24 Giovanna Zuddas Prodotto cancella - rughe
US20030093297A1 (en) * 2001-11-08 2003-05-15 Schilling Kurt Matthew Method for providing feedback as to product efficacy
US20030161853A1 (en) * 2002-01-17 2003-08-28 L'oreal Methylglycinediacetic acid and deribatives thereof useful as exfoliating agents
US8420699B1 (en) 2002-06-19 2013-04-16 Irvine L. Dubow Composition and methods of treatment using deionized and ozonated solution
US7897642B1 (en) * 2002-06-19 2011-03-01 Dr. Irvine Dubow Compositions and methods for dry eye syndrome
US20040126449A1 (en) * 2002-12-30 2004-07-01 Gopa Majmudar Topical composition and methods for treatment of aged or environmentally damaged skin
FR2857266B1 (fr) * 2003-07-07 2007-09-21 Jean Noel Thorel Composition a usage dermatologique et/ou cosmetique, comprenant a titre de principe actif au moins un antioxydant lipophile
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
US20050063932A1 (en) * 2003-08-14 2005-03-24 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
WO2005023968A1 (ja) * 2003-09-05 2005-03-17 Shiseido Co., Ltd. 温度感覚調整用香料組成物、感覚調整用物品並びに感覚調整方法及び香料マップ
KR100552245B1 (ko) * 2003-10-24 2006-02-14 주식회사 코리아나화장품 예덕나무 추출물을 함유하는 주름 개선 화장료 조성물
US20060264505A1 (en) * 2003-11-07 2006-11-23 Stiefel Laboratories, Inc. Dermatological compositions
US20050100621A1 (en) * 2003-11-07 2005-05-12 Popp Karl F. Dermatological compositions
US20050106194A1 (en) * 2003-11-18 2005-05-19 Mary Kay Inc. Compositions for achieving benefits in skin using key cellular metabolic intermediates
US7025966B2 (en) * 2003-12-05 2006-04-11 Mary Kay Inc. Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
US20050148906A1 (en) * 2003-12-24 2005-07-07 Gregory Skover Apparatus for treatment of the skin having a signaling marker
US20050158258A1 (en) * 2004-01-21 2005-07-21 Mary Kay Inc. Methods and compositions for the treatment of skin changes associated with aging and environmental damage
CN100574745C (zh) * 2004-02-28 2009-12-30 Lg生活健康株式会社 擦洗用化妆组合物
US20050220832A1 (en) * 2004-03-25 2005-10-06 Richard Walton Gels containing metallic soaps and coupling agents
US20090257968A1 (en) * 2004-03-25 2009-10-15 Richard Walton Gels containing anionic surfactants and coupling agents
US20060165739A1 (en) * 2005-01-06 2006-07-27 Mary Kay Inc. Alcohol-free microemulsion composition
DE102005026069A1 (de) * 2005-06-07 2006-12-14 Goldschmidt Gmbh Topische kosmetische Formulierungen zur Regulierung und Verbesserung des Feuchtigkeitsgehalts der Haut
US20070031357A1 (en) * 2005-08-02 2007-02-08 Anton Mentlik High PH compositions
TWI367109B (en) 2006-01-19 2012-07-01 Mary Kay Inc Compositions comprising kakadu plum extract or acai berry extract
JP5075345B2 (ja) * 2006-03-23 2012-11-21 花王株式会社 毛髪洗浄剤組成物
ES2385875T3 (es) 2006-05-19 2012-08-02 Mary Kay, Inc. Composiciones que comprenden compuestos de salicilato de glicerilo
KR101527829B1 (ko) 2007-04-19 2015-06-12 마리 케이 인코포레이티드 마그놀리아 추출물 함유 조성물
EP2164960A2 (de) 2007-05-25 2010-03-24 North Carolina State University Plattform zur zuführung von virusnanopartikeln an zielzellen
US8133516B2 (en) * 2008-10-31 2012-03-13 Lauer Scott D Therapeutic ultrasound gel
ES2322122B1 (es) * 2009-02-10 2010-07-16 Laboratorios Starga S.L. Composicion cosmetica para el cuidado y reparacion de telangiectasias.
US8257720B2 (en) * 2009-04-20 2012-09-04 Conopco, Inc. Stabilized cationic ammonium compounds and compositions comprising the same
CA2772626C (en) 2009-08-28 2013-12-10 Mary Kay Inc. Skin care formulations
US8324255B2 (en) 2009-09-15 2012-12-04 Conopco, Inc. Chelator stabilized cationic ammonium compounds and compositions comprising the same
CN102686213B (zh) 2010-01-12 2014-11-12 宝丽化成工业有限公司 色素沉着预防或改善剂
US20110277796A1 (en) * 2010-05-13 2011-11-17 Russel Walters Method of cleansing skin having an impaired barrier
US20110305737A1 (en) * 2010-06-09 2011-12-15 NY Derm LLC Multi-Active Microtargeted Anti-Aging Skin Cream Polymer Technology
GB201106161D0 (en) 2011-04-12 2011-05-25 Zephyros Inc Improvements in or relating to vehicle subframe reinforcement
WO2013096645A1 (en) 2011-12-20 2013-06-27 The Procter & Gamble Company Human skin sample methods and models for validating hypotheses for mechanisms driving skin pigmentation
JP5945142B2 (ja) * 2012-03-27 2016-07-05 株式会社 資生堂 しわ改善効果について化粧料を評価する方法
US8962028B2 (en) 2012-10-18 2015-02-24 MiCal Pharmaceuticals LLC—H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limited Liability Company Topical steroid composition and method
EP2967045B1 (de) 2013-03-12 2019-06-26 Mary Kay, Inc. Konservierungssystem
CA2905756C (en) * 2013-03-15 2016-11-29 Mary Kay Inc. Cosmetic compositions for reducing the appearance of cellulite or improving skin texture
WO2015066194A1 (en) * 2013-10-29 2015-05-07 Mary Kay Inc. Cosmetic compositions
MX2016013135A (es) 2014-04-30 2017-01-20 Kimberly Clark Co Composiciones y metodos para reducir el estres oxidativo.
KR102246477B1 (ko) 2014-04-30 2021-04-30 킴벌리-클라크 월드와이드, 인크. 피부 노화의 징후를 감소시키는 방법
AU2014392626B2 (en) 2014-04-30 2020-07-02 Kimberly-Clark Worldwide, Inc. Topical compositions for stimulating adipogenesis and lipogenesis to reduce the signs of skin aging
MX384469B (es) 2014-04-30 2025-03-14 Kimberly Clark Co Uso del extracto de undaria para reducir los signos de envejecimiento de la piel.
EP3470840B1 (de) 2014-06-12 2021-03-03 Hyglos Invest GmbH Demaskierung von Endotoxinen in Lösung
ES3038642T3 (en) 2015-12-31 2025-10-14 Colgate Palmolive Co Personal care composition comprising taurine, arginine, glycine
WO2019089942A1 (en) * 2017-11-02 2019-05-09 Rick Coulon Formulations for use in the transdermal delivery of proteasome inhibitors
WO2019232096A1 (en) * 2018-05-29 2019-12-05 Rr Health, Llc Compositions for topical treatment
CN113784642A (zh) * 2019-04-19 2021-12-10 株式会社资生堂 用于皮肤抗老化的方法以及装置
CN112076152A (zh) * 2020-09-23 2020-12-15 江苏地韵医疗科技有限公司 一种眼用组合物、其制备方法及用途
US20250090442A1 (en) * 2023-09-20 2025-03-20 Welmedix Llc Topical Composition For Managing Fragile Skin

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518517A (en) * 1983-03-16 1985-05-21 Colgate-Palmolive Company Non-antimicrobial deodorant cleansing composition
US4760096A (en) * 1985-09-27 1988-07-26 Schering Corporation Moisturizing skin preparation
US5380528A (en) * 1990-11-30 1995-01-10 Richardson-Vicks Inc. Silicone containing skin care compositions having improved oil control
US5643600A (en) * 1991-09-17 1997-07-01 Micro-Pak, Inc. Lipid vesicles containing avocado oil unsaponifiables
US5306486A (en) * 1993-03-01 1994-04-26 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic sunscreen composition containing green tea and a sunscreen
US5607678A (en) * 1994-08-24 1997-03-04 The Procter & Gamble Company Mild shower gel composition comprising unique thickener system which imparts improved lathering properties and modified rinse feel
US5720963A (en) 1994-08-26 1998-02-24 Mary Kay Inc. Barrier disruption treatments for structurally deteriorated skin
US5540853A (en) * 1994-10-20 1996-07-30 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5653970A (en) * 1994-12-08 1997-08-05 Lever Brothers Company, Division Of Conopco, Inc. Personal product compositions comprising heteroatom containing alkyl aldonamide compounds
US5618850A (en) * 1995-03-09 1997-04-08 Focal, Inc. Hydroxy-acid cosmetics
WO1997002090A1 (fr) * 1995-06-30 1997-01-23 Shiseido Company, Ltd. Composition en emulsion
US6008173A (en) * 1995-11-03 1999-12-28 Colgate-Palmolive Co. Bar composition comprising petrolatum
US6086903A (en) * 1996-02-26 2000-07-11 The Proctor & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
CA2253455A1 (en) * 1996-05-02 1997-11-06 The Procter & Gamble Company Topical compositions comprising dispersed surfactant complex
CN1221336A (zh) * 1996-05-02 1999-06-30 普罗克特和甘保尔公司 包含分散的表面活性剂复合物的局部用组合物
EP0926954A1 (de) * 1996-09-06 1999-07-07 Minnesota Mining And Manufacturing Company Antimikrobielle zusammensetzungen
US5804168A (en) * 1997-01-29 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for protecting and treating sun damaged skin
US5902591A (en) * 1997-04-03 1999-05-11 La Prairie Sa Stable topical cosmetic/pharmaceutical emulsion compositions containing ascorbic acid
EP0884045A1 (de) * 1997-06-06 1998-12-16 Pfizer Products Inc. Selbstbräunende Dihydroxyaceton Formulierungen mit verbesserter Stabilität und eine erhöte Abgabe erzeugend
AR017859A1 (es) * 1997-12-15 2001-10-24 Unilever Nv Una composicion cosmetica para aclarar la piel, de aplicacion topica sobre la piel humana y un metodo cosmetico para aclarar la piel que comprende la aplicacion topica sobre la misma de dicha composicion
WO1999049878A1 (en) 1998-03-31 1999-10-07 Mary Kay Inc. Skin lightening composition containing magnesium ascorbyl phosphate and uninontan-u34tm (extract formulation of cucumber extract and lemon extract)
US5945093A (en) * 1998-04-22 1999-08-31 Amway Corporation Conditioning shampoo
US6184247B1 (en) * 1999-05-21 2001-02-06 Amway Corporation Method of increasing cell renewal rate
US6495126B1 (en) * 1999-07-20 2002-12-17 Mary Kay Inc. Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
RU2251405C2 (ru) * 2000-03-27 2005-05-10 Шотт Глас Композиции для косметических препаратов, средств личной гигиены, компонентов очищающего действия, пищевых добавок, способы их получения и применения
US20020022040A1 (en) * 2000-07-10 2002-02-21 The Proctor & Gamble Company Methods of enhancing delivery of oil-soluble skin care actives
US7226583B2 (en) * 2002-08-12 2007-06-05 Hair Systems, Inc. Composition containing leukocyte extract for the whitening or lightening of skin
GB2417901B (en) * 2003-05-29 2008-01-30 Sun Pharmaceuticals Corp Sunscreen composition
US7429391B2 (en) * 2004-01-30 2008-09-30 Access Business Group International Llc Holistic composition and method for reducing skin pigmentation
CA2629711A1 (en) * 2005-11-14 2007-05-24 Tanning Research Laboratories, Inc. High sunscreen efficiency water-in-oil emulsion

Also Published As

Publication number Publication date
US20140017277A1 (en) 2014-01-16
NO20020299D0 (no) 2002-01-18
US8568752B2 (en) 2013-10-29
PE20010279A1 (es) 2001-03-07
NZ516940A (en) 2003-11-28
KR100768413B1 (ko) 2007-10-18
US9463156B2 (en) 2016-10-11
EA005099B1 (ru) 2004-10-28
US20070196314A1 (en) 2007-08-23
ES2265351T3 (es) 2007-02-16
EA200400911A1 (ru) 2005-06-30
UY26255A1 (es) 2001-01-31
NO20020299L (no) 2002-03-18
US20090238783A1 (en) 2009-09-24
US8182799B2 (en) 2012-05-22
EA009006B1 (ru) 2007-10-26
US20170020803A1 (en) 2017-01-26
PL352986A1 (en) 2003-09-22
BR0012567A (pt) 2002-04-16
US20130064847A1 (en) 2013-03-14
DE60028573T2 (de) 2007-05-16
DE60028573D1 (de) 2006-07-20
US6495126B1 (en) 2002-12-17
EP1200063B1 (de) 2006-06-07
US20100080864A1 (en) 2010-04-01
US7175837B2 (en) 2007-02-13
US8562962B2 (en) 2013-10-22
US20140377304A1 (en) 2014-12-25
CN1213730C (zh) 2005-08-10
CZ300239B6 (cs) 2009-03-25
AU6218300A (en) 2001-02-05
UA72533C2 (en) 2005-03-15
WO2001005369A1 (en) 2001-01-25
HK1043942A1 (en) 2002-10-04
EA200200185A1 (ru) 2002-12-26
CZ2002208A3 (cs) 2002-06-12
US8273338B2 (en) 2012-09-25
AR024813A1 (es) 2002-10-23
US20130209384A1 (en) 2013-08-15
US20030095940A1 (en) 2003-05-22
BR0012567B1 (pt) 2013-06-11
CN1373655A (zh) 2002-10-09
US10111828B2 (en) 2018-10-30
CA2379682C (en) 2012-01-24
US8252274B2 (en) 2012-08-28
CA2379682A1 (en) 2001-01-25
AU772445B2 (en) 2004-04-29
EP1200063A1 (de) 2002-05-02
TWI261522B (en) 2006-09-11
HK1043942B (en) 2006-11-17
KR20020047093A (ko) 2002-06-21
US7425323B2 (en) 2008-09-16
US8758784B2 (en) 2014-06-24
MXPA02000754A (es) 2003-07-14
US20090197976A1 (en) 2009-08-06
MY128963A (en) 2007-03-30

Similar Documents

Publication Publication Date Title
ATE328573T1 (de) Behandlung und zusammensetzungen zur erzielung eines hautalterungsschutzes durch corneum protease aktivatoren
DE69935345D1 (de) Methoden und zusammensetzungen zur prävention und behandlung der anämie
DE69828620D1 (de) Verfahren und zusammensetzungen zur vorbeugung und behandlung der chronologischer alterung der menschliches haut
DE69941497D1 (de) Schäumende Zusammensetzung zur Haarreinigung und Haarbehandlung
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE257385T1 (de) Zusammensetzungen und verfahren zur behandlung des erhöhten augenindruckes
WO2002080876A3 (fr) Utilisation d'un extrait d'algue phaeodactylum pour favoriser l'activite du proteasome des cellules de la peau
DE60108080D1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
GB0612417D0 (en) Compositions and methods for topical treatment of skin infection
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
ATE362757T1 (de) Kombinationen eines hemmers der sterolabsorption und eines kardiovaskulären wirkstoffes zur behandlung von kardiovaskulären indikationen
DE60112807D1 (de) Zusammensetzung zur behandlung von durch arterielle irrigationsdefekt gewebeschäden
EP1476471A4 (de) Nutraceuticals zur behandlung, zum schutz und zur wiederherstellung von bindegewebe
ATE308510T1 (de) Inhibitore der verzweigte-aminosäure-abhängigen aminotransferase und deren verwendung in der behandlung der zuckerkranke retinopathie
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
EP1506001A4 (de) Verfahren und zusammensetzungen zur behandlung von epithelläsionen in vagina, zervix und uterus
DE60327856D1 (de) Zusammensetzungen und verfahren zur hautbräunung
DE60138733D1 (de) Arzneimittel zur behandlung und vermeidung neurogener schmerzen
EP1075184A4 (de) Zusammensetzungen und verfahren zur aktiven impfung
DE60128427D1 (de) Verfahren und Einrichtungen zur elekrochemischen Behandlung eines Artikels
ATE443060T1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
ATE243690T1 (de) Substituierte 3-pyridyl-4-arylpyrrole und deren einsatz in verfahren zur therapeutischen und prophylaktischen behandlung
DE69924379D1 (de) Verbindungen und zubereitungen zur behandlung der ischämie des gewebes
EP1253930A4 (de) Methoden und zusammensetzungen zur behandlung hepatozellulären krebses

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties